Study Genentech 2021-03: Efficacy and Pharmacokinetics in the murine neutropenic thigh infection and murine neutropenic lung infection models with Acinetobacter baumannii

Project Details

StatusFinished
Effective start/end date8/02/22 → 7/02/23

Funding

  • Genentech: $211,790.75